SMS Pharmaceuticals Ltd share price logo

Sms Pharma Share Price

NSE: SMSPHARMA

BSE: 532815

Small Cap

Healthcare Sector

₹317.00

-5.45

(-1.69%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Sms Pharma Stock Performance

as on December 5, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹312.25
    ₹321.7
    downward going graph

    1.50%

    Downside

    1.48%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹176.05
    ₹335
    downward going graph

    44.46%

    Downside

    5.68%

    Upside

    downward going graph

Sms Pharma share price movements today

Previous Close
₹322.45
Open
₹321.10
Volume
3.67L
Upper Circuit
₹386.90
Lower Circuit
₹258.00
Day's Low - High
₹312.25 - ₹321.7
52 Week Low - High
₹176.05 - ₹335

Sms Pharma Historical Returns

1 Month Return
+ 11.36 %
3 Month Return
+ 29.77 %
1 Year Return
+ 23.37 %
3 Year Return
+ 276.26 %
5 Year Return
+ 231.59 %

Sms Pharma Fundamentals

as on December 5, 2025 at 4:01 pm IST

Market Cap

₹2,968.77 Cr

Return on Equity (ROE)

11

PE Ratio (TTM)

32.68

Return on capital employed (ROCE)

12.18

Industry PE ratio

42.28

Beta (LTM)

1.56

P/B Ratio

2.87

Dividend Yield

0.19

PEG Ratio

12.19

Quarterly Earnings Growth YOY

81.31

EPS (TTM)

7.6

Sector

Pharmaceuticals

Book Value

70.36

Technical Analysis

Bullish

View Technical Analysis

Sms Pharma Stock Valuation

as on December 5, 2025 at 4:01 pm IST

Sms Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-163.97x)

June 20, 2023

Today (32.68x)

December 5, 2025

Industry (42.28x)

December 5, 2025

Highest (2093.00x)

November 11, 2022

LowHigh

Today’s Price to Earnings Ratio: 32.68x

SMS Pharmaceuticals Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sms Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
SMS Pharmaceuticals Ltd image
SMS Pharmaceuticals Ltd
NA2,968.7746.32%0.6667782
Oxygenta Pharmaceutical Ltd image
Oxygenta Pharmaceutical Ltd
NA218.39103.41%0.00-10109
Hikal Ltd image
Hikal Ltd
BUY2,997.937.8%0.70901,859
Granules India Ltd image
Granules India Ltd
BUY13,610.088.51%0.645014,481
Concord Drugs Ltd image
Concord Drugs Ltd
NA75.5043.71%0.70145
See all

Sms Pharma Stock’s Investor Sentiment and Interest

Investment in SMS Pharmaceuticals Ltd Shares on INDmoney has grown by 607.25% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:607.25% versus previous 30 day period

Search interest for SMS Pharmaceuticals Ltd Stock has increased by 144% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:144% versus previous 30 day period

SMS Pharmaceuticals Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
148.8
149.43
135.34
166.64
161.48
245.8
164.45
196.75
173.35
248.2
196.05
242.43
Other Income
2.21
1.26
0.51
0.81
1.49
1.65
1.37
1.3
2.13
1.42
0.59
1.43
Total Income
151.02
150.68
135.85
167.45
162.97
247.44
165.82
198.05
175.48
249.62
196.64
243.86
Expenses
130.29
126.19
109.16
138.82
132.48
212.18
130.94
165.28
140.14
207.39
156.68
194.06
Operating Profit
18.51
23.24
26.18
27.82
29
33.62
33.51
31.47
33.21
40.81
39.37
48.37
Operating Profit Margin %
12.44%
15.55%
19.34%
16.69%
17.96%
13.68%
20.38%
15.99%
19.16%
16.44%
20.08%
19.95%
Profit Before Interest, Tax and Depreciation
20.73
24.49
26.7
28.63
30.49
35.26
34.88
32.77
35.34
42.23
39.96
49.8
Interest
5.94
5.89
6.32
5.57
5.95
5.61
4.67
4.61
4.2
5.07
5.84
5.74
Depreciation
8.12
7.97
7.69
7.9
8.01
7.92
8.38
8.62
8.7
8.64
9.75
10.02
Profit Before Tax
6.67
10.63
12.69
15.16
16.53
21.73
21.83
19.54
22.44
28.52
24.37
34.04
Tax Paid
1.39
2.57
3.87
3.11
4.24
5.69
5.46
5.68
5.36
8.44
5.65
8.91
Profit After Tax
5.28
8.07
8.81
12.05
12.29
16.05
16.37
13.86
17.08
20.08
18.71
25.13
Total Net profit including share of profit / Loss from associate company
3.77
6.22
9.34
11.73
11.48
17.28
16.47
14.1
18.24
20.31
20.49
25.31
EPS
0.44
0.73
1.1
1.39
1.36
2.04
1.95
1.67
2.15
2.4
2.31
2.84
Actual EPS
0.44
0.73
1.1
1.39
1.36
2.04
1.95
1.67
2.15
2.4
2.31
2.84
Adjusted EPS
0.44
0.73
1.1
1.39
1.36
2.04
1.95
1.67
2.15
2.4
2.31
2.84
Diluted EPS
0.44
0.73
1.1
1.39
1.36
2.04
1.95
1.67
2.15
2.4
2.31
2.84

SMS Pharmaceuticals Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
438.12
462.68
464.91
411.95
563.18
519.87
522.05
709.26
782.75
Other Income
1.45
2.39
3.4
5.11
3.45
5.2
4.91
4.46
6.22
Total Income
439.57
465.06
468.31
417.06
566.63
525.07
526.97
713.72
788.97
Expenses
363.33
369.34
374.81
332.03
442.07
405.55
467.58
592.64
643.76
Operating Profit
74.79
93.34
90.1
79.92
121.11
114.32
54.47
116.62
138.99
Operating Profit Margin %
17.07%
20.17%
19.38%
19.4%
21.5%
21.99%
10.43%
16.44%
17.76%
Profit Before Interest, Tax and Depreciation
76.25
95.73
93.5
85.03
124.56
119.53
59.39
121.08
145.22
Interest
15.49
15.48
11.87
12.21
11.16
18.88
21.91
23.46
18.54
Depreciation
19.18
19.9
19.27
22.07
22.28
32.15
32.13
31.52
34.34
Profit Before Tax
41.58
60.35
62.36
50.75
91.12
68.5
5.35
66.1
92.34
Tax Paid
5.96
19.89
20.9
18.07
30.16
0.62
1.47
16.91
24.94
Profit After Tax
35.61
40.45
41.45
32.69
60.96
67.88
3.88
49.2
67.4
Total Net profit including share of profit / Loss from associate company
28.48
31.75
40.04
31.58
62.52
62.22
-7.06
49.83
69.14
EPS
3.37
3.75
4.73
3.73
7.39
7.35
-0.83
5.89
8.16
Actual EPS
3.37
3.75
4.73
3.73
7.39
7.35
-0.83
5.89
8.16
Adjusted EPS
3.37
3.75
4.73
3.73
7.39
7.35
-0.83
5.89
8.16
Diluted EPS
3.37
3.75
4.73
3.73
7.39
7.35
-0.83
5.89
8.16

SMS Pharmaceuticals Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
61.22
73.47
31.81
49.76
39.71
90.45
45.06
22.45
50.12
81.71
Cash Flow from Investing Activities
-96.72
-39.26
-16.58
-34.68
-42.56
-151.6
-27.15
-29.76
-52.07
-123.42
Cash Flow from Financing Activities
26.65
-33.19
-14.89
-12.92
-2.4
92.03
-11.76
-31.97
30.69
47.07
Net Cash Flow
-8.84
1.03
0.35
2.17
-5.25
30.88
6.16
-39.28
28.73
5.36

Sms Pharma Stock Shareholding Pattern

Numbers in percentages

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
64.29%
64.32%
64.32%
64.32%
64.67%
64.67%
64.67%
64.67%
66.26%
66.26%
68.07%
DII
0%
0%
0%
0%
1.98%
2.13%
2.55%
2.55%
2.43%
3.03%
2.88%
FII
0%
0%
0.6%
0.59%
0.17%
0.17%
0.52%
0.31%
0.08%
0.03%
0.28%
Public
35.12%
35.01%
35.08%
35.09%
33.17%
33.03%
32.26%
32.47%
31.22%
30.67%
28.78%
Total Outstanding Shares
8,46,52,030
8,46,52,030
8,46,52,030
8,46,52,030
8,46,52,030
8,46,52,030
8,46,52,030
8,46,52,030
8,86,52,030
8,86,52,030
9,36,52,030
Total Shareholders
25,537
24,653
25,246
25,341
30,140
31,780
33,136
34,973
35,332
33,652
34,157

Mutual Funds that own Sms Pharma Stock

Check out the Mutual Funds with significant holdings in Sms Pharma.

Sms Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Sms Pharma.

  • SMS Pharmaceuticals Ltd Earnings Results

    SMS Pharmaceuticals Ltd’s net profit jumped 79.5% since last year same period to ₹25.31Cr in the Q2 2025-2026. On a quarterly growth basis, SMS Pharmaceuticals Ltd has generated 23.52% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • SMS Pharmaceuticals Ltd Dividends May,2025

    In the quarter ending March 2025, SMS Pharmaceuticals Ltd has declared dividend of ₹0.40 per share on 30 May 2025 - translating a dividend yield of 0.13%.

    Read More about Dividends

Indices Featuring Sms Pharma Stock

Check stock indices that include Sms Pharma.

BSE Healthcare

₹44,425.69

-0.13 (▲-56.79%)

BSE Small-Cap

₹51,093.23

-0.67 (▲-345.67%)

Insights on SMS Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 5 quarters, 14.1 Cr → 25.31 Cr (in ₹), with an average increase of 13.2% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 196.64 Cr → 243.86 Cr (in ₹), with an average increase of 19.4% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, SMSPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, SMSPHARMA stock has moved up by 11.4%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.03% to 0.28% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 66.26% to 68.07% in Sep 2025 quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, SMSPHARMA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 3.03% to 2.88% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 30.67% to 28.78% in Sep 2025 quarter

About SMS Pharmaceuticals Ltd

SMS Pharmaceuticals Limited is a public company founded in December 1987. Focused on manufacturing Active Pharmaceutical Ingredients and intermediates, the company has two facilities in Hyderabad and one in Vijayanagaram Dist. During 2015, the company successfully completed US FDA audits, filed nine Drug Master Files, and became an associate company of M/s. VKT Pharma Private Limited by acquiring 1,225,900 equity shares. During 2016-17, the company also acquired 511,400 shares in Sireen Drugs Private Limited and invested in SMS Lifesciences India Limited. 2017-18 saw the Scheme of Arrangement between Demerged and Resulting Companies, approved by Hon’ble National Company Law Tribunal and investment of 784,100 equity shares in VKT Pharma PVT LTD. In FY 2018-19, the company had 38,501,65 equity shares in VKT Pharma PVT LTD.

Revenue: ₹242.43Cr as on September 2025 (Q2 FY26)
Net Profit: ₹25.13Cr as on September 2025 (Q2 FY26)
Listing date: 28 Feb, 2007
Chairperson Name: P Ramesh Babu
OrganisationSMS Pharmaceuticals Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
CEOP Ramesh Babu
E-voting on sharesClick here to vote

FAQs

What is Sms Pharma share price today?

Sms Pharma share price today stands at ₹317 as on at the close of the market. Sms Pharma share today touched a day high of ₹321.7 and a low of ₹312.25.

What is the 52 week high and 52 week low range for Sms Pharma share?

Sms Pharma touched a 52 week high of ₹335 and a 52 week low of ₹176.05. Sms Pharma share price today i.e. is closed at ₹317, which is -5.37% down from its 52 week high and 80.06% up from its 52 week low.

What is Sms Pharma's market capitalisation today?

Sms Pharma market capitalisation is ₹2,968.77 Cr as on .

How to buy Sms Pharma shares?

To buy Sms Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SMSPHARMA or SMS Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Sms Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sms Pharma trading volume today?

Sms Pharma trading volume is 3.67L as on . This means that 3.67L shares of Sms Pharma were bought and sold on the stock market during today's trading session.